Moreover, MM cells treated with low concentrations of SB216763 mainly promote GSK3α inactivation, as evidenced by a stronger reduction of phospho-Tyr279-GSK3α than phospho-Tyr216-GSK3β. The gene discussed is GSK3A; the disease is Miyoshi myopathy.